Email updates

Keep up to date with the latest news and content from BMC Musculoskeletal Disorders and BioMed Central.

Download references

Open Access Highly Accessed

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

Daniel R Murphy*, Lee J Smolen, Timothy M Klein and Robert W Klein

  • * Corresponding author: Daniel R Murphy drm@mdm-inc.com

  • † Equal contributors

BMC Musculoskeletal Disorders 2012, 13:213  doi:10.1186/1471-2474-13-213

Include


Format